Issue 29, 2016

Discovery of a 19F MRI sensitive salinomycin derivative with high cytotoxicity towards cancer cells

Abstract

Salinomycin is a promising anti-cancer agent which selectively targets cancer stem cells. To improve its potency and selectivity, an analog library of salinomycin was generated by site-specific modification and CuAAc derivatization. Through a cytotoxicity analysis of the library, a fluorinated analog with high potency, selectivity, and 19F MRI sensitivity was discovered as a novel theranostic agent.

Graphical abstract: Discovery of a 19F MRI sensitive salinomycin derivative with high cytotoxicity towards cancer cells

Associated articles

Supplementary files

Article information

Article type
Communication
Submitted
19 Feb 2016
Accepted
10 Mar 2016
First published
10 Mar 2016

Chem. Commun., 2016,52, 5136-5139

Discovery of a 19F MRI sensitive salinomycin derivative with high cytotoxicity towards cancer cells

Q. Shi, Y. Li, S. Bo, X. Li, P. Zhao, Q. Liu, Z. Yang, H. Cong, H. Deng, M. Chen, S. Chen, X. Zhou, H. Ding and Z. Jiang, Chem. Commun., 2016, 52, 5136 DOI: 10.1039/C6CC01508E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements